HPV and oral contraceptives

Evidence suggests that long-term use of combined oral contraceptives or progestogen-only injectable contraceptives is associated with a small increased risk of cervical cancer. The level of risk returns to that for never-users within 10 years of stopping use.
Oral contraceptives and cervical cancer (245kb PDF)

The NHS Cervical Screening Programme responds to a systematic review of cervical cancer and use of hormonal contraceptives published in The Lancet and explains why women should choose to accept their invitations for cervical screening.

Research examining the effects of long-term use of oral contraceptives on the occurrence of cervical cancer in women with Human Papillomavirus (HPV) has been published in The Lancet.